Analyst Recommendations
11.90
-0.19
(-1.57%)
08/13/2026
Intellia Therapeutics, Inc. (NTLA)2026: Total Recommendations Consensus
| To Grade | # of Recommendations |
|---|---|
| Buy | 12 |
| Neutral | 4 |
| Market Outperform | 3 |
| Equal-Weight | 2 |
| Sector Perform | 1 |
| Sell | 1 |
| Underperform | 1 |
| Outperform | 1 |
| Market Perform | 1 |
5 records were shown. To view all data, Upgrade to PRO plan!
Upgrades & Downgrades